{
    "2019-09-12": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Consumer groups, unions urge caution on $63 billion AbbVie deal for Allergan",
                "features": {
                    "keywords": [
                        "consumer groups",
                        "unions",
                        "caution",
                        "AbbVie",
                        "Allergan",
                        "deal"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Gilead Tops List of Most Innovative Drug Companies",
                "features": {
                    "keywords": [
                        "Gilead",
                        "innovative",
                        "drug companies"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Humira Sales Will Crash To $3 Billion â€” Why AbbVie Stock Got An Upgrade",
                "features": {
                    "keywords": [
                        "Humira",
                        "sales",
                        "crash",
                        "AbbVie",
                        "upgrade"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Buy AbbVie Stock, Because Its Deal for Allergan Just Might Work, Analyst Says",
                "features": {
                    "keywords": [
                        "buy",
                        "AbbVie",
                        "stock",
                        "deal",
                        "Allergan",
                        "analyst"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie Stock Rises After UBS Upgrades To Buy",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "stock",
                        "rises",
                        "UBS",
                        "upgrades",
                        "buy"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Anxious About AbbVie? Here Are 4 Things You Should Know",
                "features": {
                    "keywords": [
                        "anxious",
                        "AbbVie",
                        "things",
                        "know"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}